INTERNATIONAL PROGRAMME ON CHEMICAL …

1 1 WHO/IPCS/IRA/12/04 UNITED NATIONS ENVIRONMENT PROGRAMME INTERNATIONAL LABOUR ORGANISATION WORLD HEALTH ORGANIZATION INTERNATIONAL PROGRAMME ON CHEMICAL SAFETY INTEGRATED RISK assessment : NONYLPHENOL CASE STUDY REPORT PREPARED FOR THE WHO/UNEP/ILO INTERNATIONAL PROGRAMME ON CHEMICAL SAFETY The issue of this document does not constitute formal publication. It should not be reviewed, abstracted, or quoted without the written permission of the INTERNATIONAL PROGRAMME on CHEMICAL Safety, WHO, Geneva, Switzerland.

2 WHO/IPCS/IRA/12/04 2 INTEGRATED RISK assessment : NONYLPHENOL CASE STUDY Bontje , Hermens , Vermeire , Damstra 1 University of Utrecht, Institute for Risk assessment Sciences, Utrecht, The Netherlands 2 National Institute for Public Health and the Environment, Bilthoven, The Netherlands 3 World Health Organization, Interregional Research Unit, Research Triangle Park, North Carolina, USA Comments and peer-review was provided by an IPCS working group consisting of the following scientific experts: Robert Kr es, The Netherlands.

3 Robert MacPhail, US Environmental Protection Agency, USA; Wayne Munns, US Environmental Protection Agency, USA; Peter P rt, Joint Research Centre, Italy; Larry Reiter, US Environmental Protection Agency, USA; Peter Ross, Institute of Ocean Sciences, Canada; Jun Sekizawa, Tokushima University, Japan; Glenn Suter, US Environmental Protection Agency, USA; Glen Van Der Kraak, University of Guelph, Canada; Theo Vermeire, National Institute of Public Health and the Environment, The Netherlands.

4 3 1. STRATEGIC APPROACH FOR DEVELOPMENT OF CASE STUDY ..6 2. INTRODUCTION TO NONYLPHENOL ..9 3. INTEGRATED RISK assessment OF PROBLEM FORMULATION Introduction ..12 Potential benefits of integration Environmental Risk assessment (ERA) and Human Health Risk assessment (HHRA) knowledge ..12 assessment 12 Potential Integration benefits .. 12 Impetus for the assessment .. 12 assessment Endpoints .. 13 Potential Integration benefits .. 13 Conceptual 13 Potential Integration benefits .. 13 Integration of the Analysis Plan.

5 14 Potential Integration benefits .. 14 Integrated Risk Conclusions based on integration in the problem formulation phase ..17 EMISSION SOURCES, ENVIRONMENTAL CONCENTRATIONS AND EXPOSURE Introduction ..18 Potential benefits from integration of ERA and HHRA knowledge ..18 Risk assessment Data ..19 EU-RAR: General Data .. 19 EU-RAR: Environmental Concentration/ Data (Source EU-Risk assessment Report, 2001) .. 19 Conclusions about predicted environmental concentrations .. 20 EU-RAR: Ecological Data (Source: EU-RAR, 2001).

6 21 EU-RAR: Human Health Data (Source: EU-RAR, 2001)..21 Other Data (Source: Environment Canada, 2000).. 22 Conclusions on benefits of Introduction ..24 Risk assessment Data (Source: EU-RAR, 2001)..24 Environmental Data ..24 EU-RAR: Human Health 25 Other 25 (Source: CAN-EPA, 2001).. 25 ESTROGENIC Introduction ..26 Potential benefits by integration ERA and HHRA knowledge ..26 Risk assessment Data ..28 EU-RAR: (Source: EU-RAR, 2002) .. 28 In vitro data on ecological endocrine effects.

7 28 In vivo data on ecological endocrine 28 Summary of ecological endocrine effects .. 28 EU-RAR: Human Health Data (Source: EU-RAR, 2002)..28 In vitro data on human endocrine effects .. 28 In vivo data on human endocrine effects 29 Summary of human endocrine effects EU-RAR .. 29 Other Data (Source: Environment Canada, 2000).. 30 In vitro data on ecological endocrine effects .. 30 4 Summary of ecological endocrine effects .. 31 In vitro data on human endocrine effects .. 31 Summary of human endocrine effects.

8 31 Conclusions on benefits of Conclusions missed by not 33 RISK assessment FOR Introduction ..37 Measuring NOECs for wildlife .. 37 Extrapolating rat NOAELs to NOAEL for humans ..37 Extrapolating rat NOAEL to NOECs for wildlife .. 37 Potential benefits by integration ERA and HHRA knowledge ..38 Risk assessment Data (Source: EU-RAR, 2002)..38 Environmental Data .. 38 Human Health 38 Conclusions on benefits of Differences between conclusions of the EU and Canada .. 39 Opportunities missed in the EU-RAR.

9 39 EVALUATION OF THE SCIENTIFIC BENEFITS AND DRAWBACKS OF THIS NONYLPHENOL IRA ..46 COSTS AND BENEFITS IN ECONOMICS EVALUATION OF THE IPCS 5. 6. APPENDICES ..53 APPENDIX 1: IN VIVO DATA ON ECOLOGICAL ENDOCRINE EFFECTS (SOURCE: EU-RAR, 2002) ..53 APPENDIX 2: IN VIVO DATA ON HUMAN ENDOCRINE EFFECTS (SOURCE: EU-RAR, 2002)..57 5 1. INTRODUCTION Background The INTERNATIONAL PROGRAMME on CHEMICAL Safety (IPCS) was initiated in 1980 as a collaborative PROGRAMME of the United Nations Environment PROGRAMME (UNEP), the INTERNATIONAL Labour Organisation (ILO), and the World Health Organization (WHO).

10 One of the major objectives of the IPCS is to develop and promote the use of improved methodologies for assessing the risks of CHEMICAL exposures on humans and the environment. For historical and practical reasons, human health and environmental risk assessment methodologies have generally developed independently. However, there is a need for an integrated, holistic approach to risk assessment that addresses real life situations of multi- CHEMICAL , multimedia, multi-route, and multi-species exposures.